HUMAN T-CELL LEUKEMIA VIRUSES AND ONCOGENES AND THE ORIGIN OF SOME HUMAN LEUKEMIAS AND LYMPHOMAS NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


HUMAN T-CELL LEUKEMIA VIRUSES AND ONCOGENES AND THE ORIGIN OF SOME HUMAN LEUKEMIAS AND LYMPHOMAS

Theories and Models in Cellular Transformation. Santi L, Zardi L, eds. New York, Academic Press, p. 85-100, 1985.. Unique Identifier : AIDSLINE ICDB/86626470
Gallo RC; Wong-Staal F; Clarke MF; Guo HG; Westin E; Saxinger WC; Blattner WA; Reitz MS; Lab. of Tumor Cell Biology, NCI, Bethesda, MD 20205


Abstract: Recent results obtained using acutely transforming animal retroviruses as tools to detect, isolate, and analyze the c-onc gene in human DNA and to clarify growth and/or differentiation abnormalities in leukemias and lymphomas are discussed. In addition, explorations into the role of animal chronic leukemia viruses in the causation of leukemias and lymphomas in humans are described. The chromosomal c-onc genes, c-myb, c-myc, c-fes, and c-sis, have been studied; with the possible exception of c-sis in glioblastoma and sarcoma cell lines, expression of none of the onc genes is highly correlated with specific neoplasias. The human retrovirus, human T-cell leukemia/lymphoma virus (HTLV) is now listed with the leukemia viruses; it is a novel, exogenous, horizontally transmitted type-C retrovirus. There are now more than 20 HTLV isolates comprising distinct groups obtained from patients from many parts of the world, including Japan, the United States, the Caribbean, and Israel. Cord blood T-cells infected with HTLV in vitro exhibit some properties observed in transformed cells as well as in tumor cells from Japanese adult T-cell leukemia (ATL) patients. Like many of the animal chronic leukemia viruses, HTLV does not always induce disease. A gene has recently been cloned that is not associated with HTLV sequences, but is expressed at high levels in HTLV-infected cell lines and not in their infected counterparts. Its expression may be linked to T-cell growth factor expression or response, and may somehow be indirectly induced by HTLV infection. The origin of HTLV may have been in non-human primates in Africa, with transmission to the Caribbean and surrounding regions via the slave trade, and to Japan via Portuguese explorers. (62 Refs)
Keywords: Antibodies, Viral/ANALYSIS Cell Transformation, Neoplastic Cell Transformation, Viral Chromosome Mapping Human HTLV-BLV Viruses/IMMUNOLOGY/ISOLATION & PURIF Leukemia/*ETIOLOGY/GENETICS/MICROBIOLOGY Lymphoma/*ETIOLOGY/GENETICS/MICROBIOLOGY *Oncogenes Retroviridae Infections/*GENETICS/MICROBIOLOGY/TRANSMISSION MEETING PAPER

KWDantibodies,viral/analysiscelltransformation,neoplasticcelltransformation,viralchromosomemappinghumanhtlv-blvviruses/immunology/isolation&purifleukemia/KWDetiology/genetics/microbiologylymphoma/KWDetiology/genetics/microbiologyKWDoncogenesretroviridaeinfections/KWDgenetics/microbiology/transmissionmeetingpaper
861130
M86B0235


Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .